{
    "pmid": "41471111",
    "title": "Oral Treatment of Obesity by GLP-1 and Its Analogs.",
    "abstract": "Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics for treatment of type 2 diabetes mellitus and have since become an established drug class for improving glycemic control. The interest in GLP-1 for obesity treatment has surged in 2015 after the approval of Saxenda",
    "disease": "diabetes mellitus",
    "clean_text": "oral treatment of obesity by glp and its analogs obesity is a multifaceted disease that significantly increases the risk of various chronic conditions glp r co agonists first emerged as therapeutics for treatment of type diabetes mellitus and have since become an established drug class for improving glycemic control the interest in glp for obesity treatment has surged in after the approval of saxenda"
}